Icecure Medical

Company Profile

Icecure Medical had its IPO on 2021-08-26 under the ticker symbol ICCM.

The company operates in the Healthcare sector and Medical Devices industry. Icecure Medical has a staff strength of 65 employees.

Stock update

Shares of Icecure Medical opened at $1.08 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.08 - $1.11, and closed at $1.11.

This is a 0% increase from the previous day's closing price.

A total volume of 48,826 shares were traded at the close of the day’s session.

In the last one week, shares of Icecure Medical have increased by +0.91%.

Icecure Medical's Key Ratios

Icecure Medical has a market cap of $50.79 million, indicating a price to book ratio of 2.4098 and a price to sales ratio of 10.749.

In the last 12-months Icecure Medical’s revenue was $3.22 million with a gross profit of $1.45 million and an EBITDA of $-15769000. The EBITDA ratio measures Icecure Medical's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Icecure Medical’s operating margin was -499.1% while its return on assets stood at -43.2% with a return of equity of -83.97%.

In Q2, Icecure Medical’s quarterly earnings growth was a positive 0% while revenue growth was a positive 22.5%.

Icecure Medical’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.42 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Icecure Medical’s profitability.

Icecure Medical stock is trading at a EV to sales ratio of 6.8481 and a EV to EBITDA ratio of -1.5378. Its price to sales ratio in the trailing 12-months stood at 10.749.

Icecure Medical stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$22.69 million

Total Liabilities

$3.86 million

Operating Cash Flow

$0

Capital Expenditure

$72000

Dividend Payout Ratio

0%

Icecure Medical ended 2024 with $22.69 million in total assets and $0 in total liabilities. Its intangible assets were valued at $22.69 million while shareholder equity stood at $18.44 million.

Icecure Medical ended 2024 with $0 in deferred long-term liabilities, $3.86 million in other current liabilities, in common stock, $-83066000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $3.03 million and cash and short-term investments were $3.03 million. The company’s total short-term debt was $208,000 while long-term debt stood at $0.

Icecure Medical’s total current assets stands at $20.43 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $707000.00 compared to accounts payable of $652000.00 and inventory worth $2.75 million.

In 2024, Icecure Medical's operating cash flow was $0 while its capital expenditure stood at $72000.

Comparatively, Icecure Medical paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.11

52-Week High

$2.6

52-Week Low

$0.75

Analyst Target Price

$3.93

Icecure Medical stock is currently trading at $1.11 per share. It touched a 52-week high of $2.6 and a 52-week low of $2.6. Analysts tracking the stock have a 12-month average target price of $3.93.

Its 50-day moving average was $1.12 and 200-day moving average was $1.19 The short ratio stood at 0.2 indicating a short percent outstanding of 0%.

Around 4699.7% of the company’s stock are held by insiders while 79.9% are held by institutions.